Is CD34 truly a negative marker for mesenchymal stromal cells?

被引:179
|
作者
Lin, Ching-Shwun [1 ]
Ning, Hongxiu [1 ]
Lin, Guiting [1 ]
Lue, Tom F. [1 ]
机构
[1] Univ Calif San Francisco, Dept Urol, Sch Med, Knuppe Mol Urol Lab, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
adipose; bone marrow; CD34; mesenchymal stromal cell; mesenchymal stromal cell marker; Stro-1; HEMATOPOIETIC STEM-CELLS; HUMAN ADIPOSE-TISSUE; HUMAN BONE-MARROW; IN-VIVO; ENDOTHELIAL-CELLS; EXPRESSION; MICE; DIFFERENTIATION; PRECURSORS; PHENOTYPE;
D O I
10.3109/14653249.2012.729817
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The prevailing school of thought is that mesenchymal stromal cells (MSC) do not express CD34, and this sets MSC apart from hematopoietic stem cells (HSC), which do express CD34. However, the evidence for MSC being CD34(-) is largely based on cultured MSC, not tissue-resident MSC, and the existence of CD34(-) HSC is in fact well documented. Furthermore, the Stro-1 antibody, which has been used extensively for the identification/isolation of MSC, was generated by using CD34(+) bone marrow cells as immunogen. Thus, neither MSC being CD34(-) nor HSC being CD34(+) is entirely correct. In particular, two studies that analyzed CD34 expression in uncultured human bone marrow nucleated cells found that MSC (BMSC) existed in the CD34(+) fraction. Several studies have also found that freshly isolated adipose-derived MSC (ADSC) express CD34. In addition, all of these ADSC studies and several other MSC studies have observed a disappearance of CD34 expression when the cells are propagated in culture. Thus the available evidence points to CD34 being expressed in tissue-resident MSC, and its negative finding being a consequence of cell culturing.
引用
收藏
页码:1159 / 1163
页数:5
相关论文
共 50 条
  • [1] CD34 stromal stain as a prognostic marker of scleroderma
    Lee, J.
    Park, H.
    Yoon, H.
    Chung, J.
    Cho, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : S267 - S267
  • [2] Significance of CD34 Negative Hematopoietic Stem Cells and CD34 Positive Mesenchymal Stem Cells - A Valuable Dimension to the Current Understanding
    Viswanathan, Chandra
    Kulkarni, Rohit
    Bopardikar, Abhijit
    Ramdasi, Sushilkumar
    CURRENT STEM CELL RESEARCH & THERAPY, 2017, 12 (06) : 476 - 483
  • [3] Induction of Expression of CD271 and CD34 in Mesenchymal Stromal Cells Cultured as Spheroids
    Bellagamba, Bruno Correa
    Grudzinski, Patricia Bencke
    Ely, Pedro Bins
    Hartmann Nader, Paulo de Jesus
    Nardi, Nance Beyer
    Meirelles, Lindolfo da Silva
    STEM CELLS INTERNATIONAL, 2018, 2018
  • [4] CD34 IS A SENSITIVE MARKER OF GASTROINTESTINAL STROMAL CELL TUMORS
    MIKHAEL, A
    GOWN, AM
    BACCHI, CE
    MA, CK
    ZARBO, RJ
    LABORATORY INVESTIGATION, 1993, 68 (01) : A49 - A49
  • [5] CD34 Expression in the Stromal Cells of Alveolar Adenoma
    De Rosa, Nicolina
    Maiorino, Alfonso
    De Rosa, Ilaria
    Curcio, Carlo
    Sellitto, Carmine
    Amore, Dario
    CASE REPORTS IN MEDICINE, 2012, 2012
  • [6] CD34 positive stromal cells in gastric adenocarcinornas
    Nakayama, H
    Enzan, H
    Miyazaki, E
    Kuroda, N
    Naruse, K
    Kiyoku, H
    Toi, M
    Hiroi, M
    JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (11) : 846 - 848
  • [7] BONE MARROW-DERIVED CD34 NEGATIVE FRACTION: AN ALTERNATIVE SOURCE TO ISOLATE LARGE NUMBERS OF MESENCHYMAL STROMAL CELLS
    Bernardo, M. E.
    Ingo, D.
    Aiuti, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S115 - S115
  • [8] CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization
    Copland, Ian
    Sharma, Kapil
    Lejeune, Laurence
    Eliopoulos, Nicoletta
    Stewart, Duncan
    Liu, Peter
    Lachapelle, Kevin
    Galipeau, Jacques
    EXPERIMENTAL HEMATOLOGY, 2008, 36 (01) : 93 - 103
  • [9] CD34 is a marker of mature murine mast cells
    McNagny, K
    Drew, E
    Merkens, H
    Chelliah, S
    Doyonnas, R
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 122 - 122
  • [10] CD34 expression in surface CD34 negative cell lines
    Uhr, MR
    Bosshard, G
    Cavalli, F
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 158 - 158